RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Capital expenditures

AbbVie Inc.【ABBV】

Market cap
$395.6B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-974+25.35%
Dec 31, 2023-777+11.80%
Dec 31, 2022-695-11.69%
Dec 31, 2021-787-1.38%
Dec 31, 2020-798+44.57%
Dec 31, 2019-552-13.48%
Dec 31, 2018-638+20.60%
Dec 31, 2017-529+10.44%
Dec 31, 2016-479-9.96%
Dec 31, 2015-532-13.07%
Dec 31, 2014-612+24.64%
Dec 31, 2013-491

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)